ES450681A1 - Procedimiento para la produccion de derivados del 4-(3-al- quil-aminopropoxi-indol. - Google Patents

Procedimiento para la produccion de derivados del 4-(3-al- quil-aminopropoxi-indol.

Info

Publication number
ES450681A1
ES450681A1 ES450681A ES450681A ES450681A1 ES 450681 A1 ES450681 A1 ES 450681A1 ES 450681 A ES450681 A ES 450681A ES 450681 A ES450681 A ES 450681A ES 450681 A1 ES450681 A1 ES 450681A1
Authority
ES
Spain
Prior art keywords
methyl
phenyl
blocade
butylaminopropoxy
adrenoceptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES450681A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES450681A1 publication Critical patent/ES450681A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES450681A 1975-08-15 1976-08-13 Procedimiento para la produccion de derivados del 4-(3-al- quil-aminopropoxi-indol. Expired ES450681A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1071475 1975-08-15

Publications (1)

Publication Number Publication Date
ES450681A1 true ES450681A1 (es) 1977-11-16

Family

ID=4366041

Family Applications (1)

Application Number Title Priority Date Filing Date
ES450681A Expired ES450681A1 (es) 1975-08-15 1976-08-13 Procedimiento para la produccion de derivados del 4-(3-al- quil-aminopropoxi-indol.

Country Status (28)

Country Link
US (1) US4434176A (es)
JP (2) JPS5223073A (es)
AT (1) AT363070B (es)
AU (1) AU505719B2 (es)
BE (1) BE845197R (es)
CA (1) CA1080720A (es)
CY (1) CY1225A (es)
DE (1) DE2635209C2 (es)
DK (1) DK152120C (es)
ES (1) ES450681A1 (es)
FI (1) FI63751C (es)
FR (1) FR2320743A2 (es)
GB (2) GB1575510A (es)
HK (1) HK35884A (es)
IE (1) IE43797B1 (es)
IL (2) IL50263A (es)
KE (1) KE3404A (es)
MY (1) MY8500135A (es)
NL (2) NL176362C (es)
NO (1) NO762735L (es)
NZ (1) NZ181764A (es)
PH (1) PH13356A (es)
PT (1) PT65477B (es)
SE (1) SE414633B (es)
SG (1) SG84883G (es)
SU (1) SU649313A3 (es)
YU (1) YU198876A (es)
ZA (1) ZA764883B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2830211A1 (de) * 1977-07-21 1979-02-01 Sandoz Ag Substituierte indol-derivate, ihre herstellung und verwendung
JPS58106499A (ja) * 1981-12-19 1983-06-24 株式会社東芝 燃料交換装置のクランプ解除機構
HU196125B (en) * 1985-02-05 1988-10-28 Sandoz Ag Process for producing pharmaceutical comprising 3-(aminopropoxy)-indole derivatives combined with diuretic
US5174210A (en) * 1990-04-27 1992-12-29 Heidelberger Druckmaschinen Aktiengesellschaft Preparation of the inking unit of a printing press for a change of printing job
JPH09508378A (ja) * 1994-01-28 1997-08-26 シーエーエル・インターナショナル・リミテッド エステル化可能なβ遮断薬のサリチレートを含む医薬製造物
UA82698C2 (uk) * 2003-05-30 2008-05-12 Ранбакси Лабораториз Лимитед Заміщені похідні піролу та їх використання в якості інгібіторів hmg-co
AU2006313430B2 (en) * 2005-11-08 2012-09-06 Ranbaxy Laboratories Limited Process for (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
AR059838A1 (es) * 2006-03-14 2008-04-30 Ranbaxy Lab Ltd Formulaciones para dosis estabilizantes de estatina
CN101494980A (zh) * 2006-07-14 2009-07-29 兰贝克赛实验室有限公司 HMG-CoA还原酶抑制剂的多晶型形式及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3751429A (en) * 1970-03-24 1973-08-07 Sandoz Ltd 4-(3-amino-2-substituted propoxy)indole derivatives
CH532040A (de) * 1970-03-24 1972-12-31 Sandoz Ag Verfahren zur Herstellung neuer Indolderivate
SE375771B (es) * 1970-09-30 1975-04-28 Sandoz Ag
CH545783A (en) * 1971-01-07 1974-02-15 Novel indole derivs - prepn by reacting 4-(2-hydroxy-3-isopropylaminopropoxy) indoles and acid anhy-drides
CH545784A (en) * 1971-01-07 1974-02-15 Beta blocking and anti-arrhythmic indole derivs - prepd by catalytic de-benzylation of 4-(3-benzyl aminopropoxy) indoles

Also Published As

Publication number Publication date
PT65477A (fr) 1976-09-01
ATA602576A (de) 1980-12-15
NL176362B (nl) 1984-11-01
FI63751B (fi) 1983-04-29
IL50263A0 (en) 1976-10-31
DE2635209A1 (de) 1977-02-24
DK357576A (da) 1977-02-16
DE2635209C2 (de) 1983-01-27
JPS568834B2 (es) 1981-02-25
PH13356A (en) 1980-03-20
IL50263A (en) 1980-06-30
GB1575510A (en) 1980-09-24
ZA764883B (en) 1978-03-29
PT65477B (fr) 1978-05-10
GB1575509A (en) 1980-09-24
IE43797B1 (en) 1981-06-03
BE845197R (fr) 1977-02-14
YU198876A (en) 1982-05-31
IE43797L (en) 1977-02-15
US4434176A (en) 1984-02-28
MY8500135A (en) 1985-12-31
SG84883G (en) 1985-01-11
IL58163A0 (en) 1979-12-30
NL930134I1 (nl) 1993-11-01
CY1225A (en) 1984-04-06
FR2320743B2 (es) 1978-11-17
NL176362C (nl) 1985-04-01
SU649313A3 (ru) 1979-02-25
AU505719B2 (en) 1979-11-29
NZ181764A (en) 1978-06-20
FR2320743A2 (fr) 1977-03-11
CA1080720A (en) 1980-07-01
NO762735L (es) 1977-02-16
AU1684176A (en) 1978-02-16
FI762258A (es) 1977-02-16
HK35884A (en) 1984-05-04
FI63751C (fi) 1983-08-10
NL7608902A (nl) 1977-02-17
SE414633B (sv) 1980-08-11
JPS5649318A (en) 1981-05-02
DK152120C (da) 1988-06-20
DK152120B (da) 1988-02-01
NL930134I2 (nl) 1996-11-01
JPS5223073A (en) 1977-02-21
AT363070B (de) 1981-07-10
SE7608865L (sv) 1977-02-16
KE3404A (en) 1985-02-01

Similar Documents

Publication Publication Date Title
ES430709A1 (es) Procedimiento para la obtencion de un medio fungicida a ba-se de derivados de 1-propil-imidazol.
ES448475A1 (es) Procedimiento de preparacion de derivados triyodados del benceno.
ES450681A1 (es) Procedimiento para la produccion de derivados del 4-(3-al- quil-aminopropoxi-indol.
ES405983A1 (es) Procedimiento para la preparacion de derivados de fenileti-lamina fluoralcohilados.
ES440426A1 (es) Un procedimiento para la preparacion de derivados de tieno- tiacina.
ES397598A1 (es) Procedimiento para preparar compuestos organicos de azufre.
ES369571A1 (es) Procedimiento para la preparacion de 1,3,4-tiadiazolil-(2)-ureas..
SE7710395L (sv) Bekempningsmedel mot skadegorare
ES8105730A1 (es) Un procedimiento para la preparacion de piridizinobenzodiazepinas
GB931923A (en) Process for inhibiting metal corrosion
ES389473A1 (es) Un procedimiento de preparacion de derivados de aminocarbo-nil-3 oxazolidinona-2.
ES428267A1 (es) Procedimiento para la produccion de derivados de guanidina.
SE7408826L (es)
ES331791A1 (es) Procedimiento para la obtencion de poli-n-oxidos.
CA1273946C (en) ANTICONVULSANT GAMMA-THIOBUTYROLACTONE DERIVATIVES
ES475588A1 (es) Procedimiento para la obtencion de derivados del acido inde-no -2,1-b- tiofen-2-oxamico
ES470751A1 (es) Procedimiento de preparacion de nuevas piridazinilhidrazonasy de sus sales farmaceuticamente aceptables
IE791781L (en) 4, 5-methano-bufadienolide rhamnosides
ES459197A1 (es) Procedimiento para preparar esteres oximicos de isonitroso- cianoacetamida.
EP0044266A3 (en) Substituted 3,5-diamino-1,2,4-oxadiazoles and 3,5-diamino-1,2,4-thiadiazoles, their preparation and use
GR74822B (es)
FR2312255B1 (es)
ES455731A1 (es) Procedimiento para la preparacion de benzamidas disustitui- das en las posiciones 2 y 5.
ES395530A1 (es) Procedimiento para la preparacion de nuevos derivados de a-cido acrilico.
ES446329A1 (es) Un procedimiento de preparacion de nuevas acetamidoximas.